Valuation OneSource Specialty Pharma Limited
Stocks
ONESOURCE
INE013P01021
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,599.90 INR | -1.45% |
|
-7.94% | -11.64% |
| 05-13 | Onesource Specialty Pharma not to pursue merger of facilities of Steriscienceat with co | RE |
| 05-13 | Onesource Specialty Pharma March-quarter consol profit 46 million rupees | RE |
Company Valuation: OneSource Specialty Pharma Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 200,521 | 183,422 | - | - |
| Change | - | -8.53% | - | - |
| Enterprise Value (EV) 1 | 200,521 | 180,604 | 192,278 | 184,586 |
| Change | - | -9.93% | -1% | -4% |
| P/E Ratio | -1,075x | -229x | 44.3x | 21.5x |
| PBR | - | 3.16x | 2.92x | 2.58x |
| PEG | - | -1x | -0x | 0x |
| Capitalization / Revenue | - | 11.9x | 8.22x | 5.41x |
| EV / Revenue | - | 12.7x | 8.62x | 5.44x |
| EV / EBITDA | - | 59.4x | 24.6x | 13.6x |
| EV / EBIT | - | 719x | 35x | 18.2x |
| EV / FCF | - | -32.2x | 49.2x | 25.2x |
| FCF Yield | - | -3.1% | 2.03% | 3.96% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -1.63 | -6.44 | 36.1 | 74.58 |
| Distribution rate | - | - | - | - |
| Net sales 1 | - | 14,216 | 22,304 | 33,914 |
| EBITDA 1 | - | 3,042 | 7,822 | 13,560 |
| EBIT 1 | - | 251.3 | 5,495 | 10,145 |
| Net income 1 | -179.7 | -738 | 4,134 | 8,540 |
| Net Debt 1 | - | 11,733 | 8,856 | 1,164 |
| Reference price 2 | 1,752.25 | 1,599.90 | 1,599.90 | 1,599.90 |
| Nbr of stocks (in thousands) | 114,436 | 114,646 | - | - |
| Announcement Date | 5/5/25 | 5/13/26 | - | - |
1INR in Million2INR
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -165.09x | 14.68x | 70.85x | - | 1.97B | |
| 29.89x | 5.3x | 16.42x | 1.1% | 43.58B | |
| -20.13x | 298.25x | -18.37x | -.--% | 34.03B | |
| 21.71x | 2.51x | 10.86x | -.--% | 29.77B | |
| 40.01x | 3.98x | 25.46x | -.--% | 29.82B | |
| 29.57x | 7.61x | 19.57x | 0.4% | 25.42B | |
| 27.44x | 4.4x | 20.03x | -.--% | 13.35B | |
| 22.01x | 1.91x | 8.41x | 1.21% | 12.85B | |
| -20.49x | 13.48x | -20.07x | -.--% | 12.22B | |
| Average | -3.90x | 39.12x | 14.80x | 0.34% | 22.56B | |
| Weighted average by Cap. | 16.17x | 54.40x | 9.56x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ONESOURCE Stock
- Valuation OneSource Specialty Pharma Limited
Select your edition
All financial news and data tailored to specific country editions
